Myovant Sciences Ltd. Principal Executive Officer Lynn Seely's 2018 pay falls 64% to $4.4M
Myovant Sciences Ltd. reports 2018 executive compensation
By ExecPay News
Published: July 25, 2019
Myovant Sciences Ltd. reported fiscal year 2018 executive compensation information on July 25, 2019.
In 2018, five executives at Myovant Sciences Ltd. received on average a compensation package of $2.6M, a 56% decrease compared to previous year.
Average pay of disclosed executives at Myovant Sciences Ltd.
Lynn Seely, Principal Executive Officer, received $4.4M in total, which decreased by 64% compared to 2017. 81% of Seely's compensation, or $3.6M, was in option awards. Seely also received $267K in non-equity incentive plan, $557K in salary, as well as $2K in other compensation.
Kim Sablich, Chief Commercial Officer, received a compensation package of $2.4M. 62% of the compensation package, or $1.5M, was in option awards.
Frank Karbe, Principal Financial and Accounting Officer, earned $2.2M in 2018, a 9% decrease compared to previous year.
Juan Camilo Arjona Ferreira, Chief Medical Officer, received $2M in 2018.
Matthew Lang, General Counsel, earned $1.8M in 2018, a 37% decrease compared to previous year.
Myovant Sciences Ltd.'s fiscal year ends on March 31.
Related executives
Lynn Seely
Myovant Sciences Ltd.
Principal Executive Officer
Frank Karbe
Myovant Sciences Ltd.
Former Principal Financial and Accounting Officer
Matthew Lang
Myovant Sciences Ltd.
General Counsel
Juan Ferreira
Myovant Sciences Ltd.
Chief Medical Officer
Kim Sablich
Myovant Sciences Ltd.
Chief Commercial Officer
You may also like
Source: SEC filing on July 25, 2019.